Endovascular Today: Computational Model Suggests a New Paradigm for Accelerated Treatment Optimization With Paclitaxel Devices

August 28, 2019ā€”CBSET announced that its scientists have published data and analyses that provide critical insights into the interplay between target anatomy and device attributes in determining balloon- and stent-based paclitaxel retention in healthy and diseased arteries. According to CBSET, these findings may transform the understanding of the safety and efficacy of paclitaxel-coated devices used in the treatment of peripheral artery disease.

The article, ā€œTaking Paclitaxel Coated Balloons to a Higher Level: Predicting Coating Dissolution Kinetics, Tissue Retention and Dosing Dynamics,ā€ by Abraham R. Tzafriri, PhD; Sahil A. Parikh, MD; and Elazer R. Edelman, MD, is available in Journal of Controlled Release (2019;310:94ā€“102).

Read full article in Endovascular Today.